Nitromint (Glyceryl Trinitrate Solution)

Glyceryl trinitrate releases nitric oxide within vascular smooth muscle cells. The nitric oxide activates guanylate cyclase, raising cyclic GMP levels, which relaxes smooth muscle and dilates veins and arteries. This reduces cardiac preload and afterload, lowers myocardial oxygen demand, and improves coronary blood flow, alleviating anginal symptoms.

The specific dose of Nitromint is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and response to therapy. Typically, a single sublingual spray or drop is used at the onset of chest pain, with additional doses allowed as directed by the healthcare professional.

Safety data for glyceryl trinitrate during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should evaluate the potential benefits against possible risks before prescribing Nitromint to pregnant or nursing women.

To request Nitromint, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nitromint belongs to the nitrate class, offering rapid onset of action for acute chest pain, whereas beta‑blockers and calcium‑channel blockers provide longer‑term control of heart rate and vascular tone. Nitrates are especially useful for immediate symptom relief, but tolerance can develop, requiring nitrate‑free intervals, a consideration less common with other classes.

Nitromint should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from moisture and direct sunlight, and keep it out of reach of children. Do not expose the product to extreme heat or freeze it, as this may affect stability.

Nitromint is administered sublingually. The patient places the prescribed number of sprays or drops under the tongue and allows the solution to dissolve without swallowing. This route provides rapid absorption into the bloodstream, delivering quick relief of anginal pain within minutes.

The most serious risks include severe hypotension, which can lead to fainting or shock, and rare cases of methemoglobinemia that impair oxygen delivery. Patients should be monitored for sudden drops in blood pressure, dizziness, or any signs of an allergic reaction, and seek immediate medical attention if these occur.

Nitromint is contraindicated in patients with known hypersensitivity to glyceryl trinitrate or other nitrates, those who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, and individuals with severe anemia, increased intracranial pressure, or uncontrolled hypotension. Clinicians should assess each patient’s medical history before initiating therapy.